BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31968989)

  • 21. Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.
    Bylicki O; Rivière F; Tournier C; Canoui-Poitrine F; Grassin F; Margery J; Prodel M; Vainchtock A; Assié JB; Chouaïd C
    Clin Lung Cancer; 2021 May; 22(3):e320-e328. PubMed ID: 32646653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of community-based palliative care on acute hospital use in the last year of life is modified by time to death, age and underlying cause of death. A population-based retrospective cohort study.
    Spilsbury K; Rosenwax L; Arendts G; Semmens JB
    PLoS One; 2017; 12(9):e0185275. PubMed ID: 28934324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study.
    Wright AA; Zhang B; Keating NL; Weeks JC; Prigerson HG
    BMJ; 2014 Mar; 348():g1219. PubMed ID: 24594868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of integrated palliative care on the quality of end-of-life care: retrospective analysis of 521 cancer patients.
    Colombet I; Montheil V; Durand JP; Gillaizeau F; Niarra R; Jaeger C; Alexandre J; Goldwasser F; Vinant P
    BMJ Support Palliat Care; 2012 Sep; 2(3):239-47. PubMed ID: 24654196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality Indicators of End-of-Life Care Among Privately Insured People With Cancer in Brazil.
    Soares LGL; Gomes RV; Palma A; Japiassu AM
    Am J Hosp Palliat Care; 2020 Aug; 37(8):594-599. PubMed ID: 31726853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of chemotherapy with palliative intent in the last 30 days of life: the balance between palliation and chemotherapy.
    Zdenkowski N; Cavenagh J; Ku YC; Bisquera A; Bonaventura A
    Intern Med J; 2013 Nov; 43(11):1191-8. PubMed ID: 23870085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity of Care, Expenditure, and Place of Death in French Women in the Year Before Their Death From Breast Cancer: A Population-Based Study.
    Tanguy-Melac A; Denis P; Fagot-Campagna A; Gastaldi-Ménager C; Laurent M; Tuppin P
    Cancer Control; 2020; 27(1):1073274820977175. PubMed ID: 33356850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-intensity end-of-life care among children, adolescents, and young adults with cancer who die in the hospital: A population-based study from the French national hospital database.
    Revon-Rivière G; Pauly V; Baumstarck K; Bernard C; André N; Gentet JC; Seyler C; Fond G; Orleans V; Michel G; Auquier P; Boyer L
    Cancer; 2019 Jul; 125(13):2300-2308. PubMed ID: 30913309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of cancer patients in their last month of life: aimless chemotherapy.
    Assi T; El Rassy E; Tabchi S; Ibrahim T; Moussa T; Chebib R; El Karak F; Farhat F; Chahine G; Nasr F; Ghosn M; Kattan J
    Support Care Cancer; 2016 Apr; 24(4):1603-8. PubMed ID: 26391890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
    Lapeyre-Prost A; Perkins G; Vallee M; Pozet A; Tougeron D; Maillet M; Locher C; Dreanic J; Legoux JL; Lièvre A; Lecaille C; Sabate JM; Mary F; Bonnetain F; Jaulmes-Bouillot H; Behal F; Landi B; Taieb J
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101709. PubMed ID: 33930588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rise of concurrent care for veterans with advanced cancer at the end of life.
    Mor V; Joyce NR; Coté DL; Gidwani RA; Ersek M; Levy CR; Faricy-Anderson KE; Miller SC; Wagner TH; Kinosian BP; Lorenz KA; Shreve ST
    Cancer; 2016 Mar; 122(5):782-90. PubMed ID: 26670795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palliative Care for Patients With Hematologic Malignancies in a Low-Middle Income Country: Prevalence of Symptoms and the Need for Improving Quality of Attention at the End of Life.
    Jaime-Pérez JC; Turrubiates-Hernández GA; Nava-Obregón T; Coronado-Hernández B; Gutiérrez-Aguirre H; Cantú-Rodríguez OG; Herrera-Garza JL; Gómez-Almaguer D
    Am J Hosp Palliat Care; 2020 Aug; 37(8):600-605. PubMed ID: 31714147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early referral to a palliative team improves end-of-life care among gynecological cancer patients: a retrospective, population-based study.
    Paulsen T; Liland H; Myklebust TÅ; Lindemann K
    Int J Gynecol Cancer; 2022 Feb; 32(2):181-188. PubMed ID: 34987096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group.
    Wein L; Rowe C; Brady B; Handolias D; Lipton L; Pook D; Stanley R; Haines I
    Intern Med J; 2017 Mar; 47(3):280-283. PubMed ID: 27658500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study.
    Hui D; Didwaniya N; Vidal M; Shin SH; Chisholm G; Roquemore J; Bruera E
    Cancer; 2014 May; 120(10):1572-8. PubMed ID: 24549743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. End-of-life palliative chemotherapy: where do we stand?
    Mohammed AA; Al-Zahrani AS; Ghanem HM; Farooq MU; El Saify AM; El-Khatib HM
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):35-9. PubMed ID: 25724226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Early Palliative Care With Chemotherapy Intensity in Patients With Advanced Stage Lung Cancer: A National Cohort Study.
    Lammers A; Slatore CG; Fromme EK; Vranas KC; Sullivan DR
    J Thorac Oncol; 2019 Feb; 14(2):176-183. PubMed ID: 30336324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. End-of-life care of women with gynecologic malignancies: a pilot study.
    Nevadunsky NS; Spoozak L; Gordon S; Rivera E; Harris K; Goldberg GL
    Int J Gynecol Cancer; 2013 Mar; 23(3):546-52. PubMed ID: 23429487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. End-of-life care for lung cancer patients in the United States and Ontario.
    Warren JL; Barbera L; Bremner KE; Yabroff KR; Hoch JS; Barrett MJ; Luo J; Krahn MD
    J Natl Cancer Inst; 2011 Jun; 103(11):853-62. PubMed ID: 21593012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific anticancer treatments in the last 3 months of life: a French experience.
    Viel E; Chaigneau L; Fanton E; Kalbacher E; Thiery-Vuillemnin A; Villanueva C; Dobi E; Curtit E; Almotlak H; Aubry R; Pivot X
    Support Care Cancer; 2013 Feb; 21(2):405-12. PubMed ID: 22736464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.